<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7243/5033661/ad5f9e9ca5e2/nihms-757208-f0013.jpg"/> </div> <div class="text-side"> <h1>CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.</h1> <p>CD82 regulates melanoma experimental metastasis in vivo by suppressing U2AF2-mediated CD44 isoform switching. (A) Quantification of tumor loci in liver 20 days post implantation of vector, CD82, scrambled shRNA, shU2AF2, shCD44s and shCD44v8-10 transfected-Lu1205M cells into nude mice. Ten mice were injected under each condition. The livers in each group were collected and sectioned. 6 sections through the center of the liver were examined under dissecting microscopy for the presence of metastatic tumor loci. Western blotting analysis was conducted to determine the levels of CD44v8-10 and CD44s in lysates from implanted tumors. (B) Quantification of primary tumor’s tumorigenic potentials. Data are mean±SEM. n=10. (C) Representative images of H&amp;E staining of liver metastases of vector, CD82, scrambled shRNA, shU2AF2 and shCD44v8-10-transfected Lu1205M cells in mice. T: metastatic tumor. (D) IHC staining of U2AF2, CD44s and CD44v8-10 in invasive fronts of primary tumor.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27041584/" target="_blank">27041584</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>